Search research articles
Contact Us
Filters
Showing results (181-190 of 224) with videos related to
Page
of 23
Sort By:
HIV Medicine
|
August 18, 2009
Long-term (96-week) follow-up of antiretroviral-naïve HIV-infected patients treated with first-line lopinavir/ritonavir monotherapy in the MONARK trial
Jade Ghosn, P Flandre, I Cohen-Codar, et al.
The New England Journal of Medicine
|
October 29, 1998
A randomized trial of three maintenance regimens given after three months of induction therapy with zidovudine, lamivudine, and indinavir in previously untreated HIV-1-infected patients. Trilège (Agence Nationale de Recherches sur le SIDA 072) Study Team
G Pialoux, F Raffi, F Brun-Vezinet, et al.
Presse Medicale (Paris, France : 1983)
|
August 3, 1988
[Mycoplasma pneumoniae infections. A multicenter retrospective study of 182 cases]
B Garo, M Garré, J J Quiot, et al.
The Journal of Eukaryotic Microbiology
|
March 21, 1998
Detection of microsporidia and identification of Enterocytozoon bieneusi in surface water by filtration followed by specific PCR
J M Sparfel, C Sarfati, O Liguory, et al.
HIV Medicine
|
January 7, 2010
Is long-term virological response related to CCR5 Delta32 deletion in HIV-1-infected patients started on highly active antiretroviral therapy?
J-J Laurichesse, A Taieb, C Capoulade-Metay, et al.
AIDS (London, England)
|
November 14, 1998
Efficacy and safety of stavudine and didanosine combination therapy in antiretroviral-experienced patients
F Raffi, V Reliquet, S Auger, et al.
Medecine Et Maladies Infectieuses
|
January 24, 2007
[Lopinavir/ritonavir in HIV-infected patient with long-term virological failure: immunovirological response and tolerance in 121 patients of the ANRS CO8 Aproco-Copilote cohort]
C Brunet-François, A Taieb, B Masquelier, et al.
HIV Clinical Trials
|
October 29, 2014
Dolutegravir: clinical and laboratory safety in integrase inhibitor-naive patients
L Curtis, G Nichols, C Stainsby, et al.
Clinical and Experimental Immunology
|
November 13, 2001
CD4 T cell recovery is slower in patients experiencing viral load rebounds during HAART
D Scott-Algara, J P Aboulker, C Durier, et al.
Public Health
|
June 30, 2021
Dramatic decline in new HIV diagnoses in persons born in France in a large nationwide HIV cohort
A Le Guillou, A Cabie, C Delpierre, et al.
Page
of 23
Search research articles
Search
Showing results (181-190 of 224) with videos related to
Sort By:
Page
of 23
HIV Medicine
|
August 18, 2009
Long-term (96-week) follow-up of antiretroviral-naïve HIV-infected patients treated with first-line lopinavir/ritonavir monotherapy in the MONARK trial
Jade Ghosn, P Flandre, I Cohen-Codar, et al.
The New England Journal of Medicine
|
October 29, 1998
A randomized trial of three maintenance regimens given after three months of induction therapy with zidovudine, lamivudine, and indinavir in previously untreated HIV-1-infected patients. Trilège (Agence Nationale de Recherches sur le SIDA 072) Study Team
G Pialoux, F Raffi, F Brun-Vezinet, et al.
Presse Medicale (Paris, France : 1983)
|
August 3, 1988
[Mycoplasma pneumoniae infections. A multicenter retrospective study of 182 cases]
B Garo, M Garré, J J Quiot, et al.
The Journal of Eukaryotic Microbiology
|
March 21, 1998
Detection of microsporidia and identification of Enterocytozoon bieneusi in surface water by filtration followed by specific PCR
J M Sparfel, C Sarfati, O Liguory, et al.
HIV Medicine
|
January 7, 2010
Is long-term virological response related to CCR5 Delta32 deletion in HIV-1-infected patients started on highly active antiretroviral therapy?
J-J Laurichesse, A Taieb, C Capoulade-Metay, et al.
AIDS (London, England)
|
November 14, 1998
Efficacy and safety of stavudine and didanosine combination therapy in antiretroviral-experienced patients
F Raffi, V Reliquet, S Auger, et al.
Medecine Et Maladies Infectieuses
|
January 24, 2007
[Lopinavir/ritonavir in HIV-infected patient with long-term virological failure: immunovirological response and tolerance in 121 patients of the ANRS CO8 Aproco-Copilote cohort]
C Brunet-François, A Taieb, B Masquelier, et al.
HIV Clinical Trials
|
October 29, 2014
Dolutegravir: clinical and laboratory safety in integrase inhibitor-naive patients
L Curtis, G Nichols, C Stainsby, et al.
Clinical and Experimental Immunology
|
November 13, 2001
CD4 T cell recovery is slower in patients experiencing viral load rebounds during HAART
D Scott-Algara, J P Aboulker, C Durier, et al.
Public Health
|
June 30, 2021
Dramatic decline in new HIV diagnoses in persons born in France in a large nationwide HIV cohort
A Le Guillou, A Cabie, C Delpierre, et al.
Page
of 23